Bourgeon Capital Management LLC Trims Stock Position in The Chemours Company $CC

Key Points

• Bourgeon Capital Management LLC reduced its position in The Chemours Company by 53.7%, owning 15,750 shares after selling 18,250 shares in Q2.
• Significant institutional investments include Principal Financial Group increasing its stake by 116.3% and Millennium Management growing its holdings by 60.4% in the first quarter.
• CEO Denise Dignam purchased 4,068 shares of Chemours at $12.06 per share, raising her total ownership to approximately $2.31 million.

Bourgeon Capital Management LLC lessened its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 53.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,750 shares of the specialty chemicals company's stock after selling 18,250 shares during the period. Bourgeon Capital Management LLC's holdings in Chemours were worth $180,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. SG Americas Securities LLC purchased a new position in shares of Chemours during the first quarter worth $822,000. Principal Financial Group Inc. increased its holdings in Chemours by 116.3% in the first quarter. Principal Financial Group Inc. now owns 742,119 shares of the specialty chemicals company's stock valued at $10,041,000 after buying an additional 399,097 shares in the last quarter. Millennium Management LLC increased its holdings in Chemours by 60.4% in the first quarter. Millennium Management LLC now owns 4,022,782 shares of the specialty chemicals company's stock valued at $54,428,000 after buying an additional 1,515,520 shares in the last quarter. Janney Montgomery Scott LLC increased its holdings in Chemours by 22.4% in the first quarter. Janney Montgomery Scott LLC now owns 31,886 shares of the specialty chemicals company's stock valued at $431,000 after buying an additional 5,843 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in Chemours by 1,115.2% in the first quarter. GAMMA Investing LLC now owns 18,617 shares of the specialty chemicals company's stock valued at $252,000 after buying an additional 17,085 shares in the last quarter. Hedge funds and other institutional investors own 76.26% of the company's stock.

Insider Transactions at Chemours

In other Chemours news, CEO Denise Dignam acquired 4,068 shares of the company's stock in a transaction that occurred on Friday, August 8th. The stock was bought at an average price of $12.06 per share, with a total value of $49,060.08. Following the purchase, the chief executive officer owned 191,546 shares in the company, valued at approximately $2,310,044.76. The trade was a 2.17% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.34% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CC. Zacks Research raised shares of Chemours from a "strong sell" rating to a "hold" rating in a report on Wednesday, August 27th. Mizuho lifted their price objective on shares of Chemours from $16.00 to $19.00 and gave the company an "outperform" rating in a report on Tuesday, September 23rd. Royal Bank Of Canada lifted their price objective on shares of Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a report on Thursday, July 3rd. Finally, Truist Financial lifted their price objective on shares of Chemours from $18.00 to $21.00 and gave the company a "buy" rating in a report on Tuesday, September 16th. Five analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $17.63.

Chemours Stock Down 0.7%

CC stock opened at $15.56 on Tuesday. The stock has a market capitalization of $2.33 billion, a P/E ratio of -5.56 and a beta of 1.61. The firm has a 50-day simple moving average of $14.83 and a 200-day simple moving average of $12.94. The company has a quick ratio of 0.83, a current ratio of 1.68 and a debt-to-equity ratio of 17.16. The Chemours Company has a 52 week low of $9.13 and a 52 week high of $22.38.

Chemours (NYSE:CC - Get Free Report) last released its earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.12. Chemours had a negative net margin of 7.19% and a positive return on equity of 35.14%. The business had revenue of $1.62 billion during the quarter, compared to analysts' expectations of $1.57 billion. During the same quarter in the previous year, the company earned $0.38 earnings per share. The company's quarterly revenue was up 5.0% on a year-over-year basis. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities analysts forecast that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 15th were paid a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Friday, August 15th. Chemours's dividend payout ratio is currently -12.50%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.